PEOPLE - Changes at Abbott Laboratories:
This article was originally published in Clinica
Executive Summary
Abbott Laboratories executive vice-president of the $4bn diagnostics division Edward Michael and executive vice-president of $1.1bn vascular medical devices division John Capek are among the group's four directors who will report directly to CEO Miles White following the sudden retirement of group No 2, COO Richard Gonzalez. Abbott is now committed to growing the diagnostics operation, after the recent collapse of GE's proposed $8.13bn takeover, but it has slipped to third in the world rankings, behind Roche and the Dade Behring-enhanced Siemens Medical Solutions Diagnostics.